Global Microbiome Drugs Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Sep-2018   |    Format :PDF   |    Number of Pages : 94
This report focuses on the global Microbiome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microbiome Drugs development in United States, Europe and China.

In 2017, the global Microbiome Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.

The key players covered in this study
    Pfizer
    Second Genome
    Seres Therapeutics
    MaaT Pharma
    Enterome Bioscience
    MicroBiome Therapeutics
    Ritter Pharmaceuticals
    Rebiotix
    OpenBiome

Market segment by Type, the product can be split into
    Probiotics
    Prebiotics
    Small Molecules
    Biological Drugs
    Other

Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Other

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Microbiome Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Microbiome Drugs development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Microbiome Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Microbiome Drugs Market Size Growth Rate by Type (2013-2025)
        1.4.2 Probiotics
        1.4.3 Prebiotics
        1.4.4 Small Molecules
        1.4.5 Biological Drugs
        1.4.6 Other
    1.5 Market by Application
        1.5.1 Global Microbiome Drugs Market Share by Application (2013-2025)
        1.5.2 Hospital Pharmacies
        1.5.3 Retail Pharmacies
        1.5.4 Online Pharmacies
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Microbiome Drugs Market Size
    2.2 Microbiome Drugs Growth Trends by Regions
        2.2.1 Microbiome Drugs Market Size by Regions (2013-2025)
        2.2.2 Microbiome Drugs Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Microbiome Drugs Market Size by Manufacturers
        3.1.1 Global Microbiome Drugs Revenue by Manufacturers (2013-2018)
        3.1.2 Global Microbiome Drugs Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Microbiome Drugs Key Players Head office and Area Served
    3.3 Key Players Microbiome Drugs Product/Solution/Service
    3.4 Date of Enter into Microbiome Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Microbiome Drugs Market Size by Type (2013-2018)
    4.2 Global Microbiome Drugs Market Size by Application (2013-2018)

5 United States
    5.1 United States Microbiome Drugs Market Size (2013-2018)
    5.2 Microbiome Drugs Key Players in United States
    5.3 United States Microbiome Drugs Market Size by Type
    5.4 United States Microbiome Drugs Market Size by Application

6 Europe
    6.1 Europe Microbiome Drugs Market Size (2013-2018)
    6.2 Microbiome Drugs Key Players in Europe
    6.3 Europe Microbiome Drugs Market Size by Type
    6.4 Europe Microbiome Drugs Market Size by Application

7 China
    7.1 China Microbiome Drugs Market Size (2013-2018)
    7.2 Microbiome Drugs Key Players in China
    7.3 China Microbiome Drugs Market Size by Type
    7.4 China Microbiome Drugs Market Size by Application

8 Japan
    8.1 Japan Microbiome Drugs Market Size (2013-2018)
    8.2 Microbiome Drugs Key Players in Japan
    8.3 Japan Microbiome Drugs Market Size by Type
    8.4 Japan Microbiome Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Microbiome Drugs Market Size (2013-2018)
    9.2 Microbiome Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Microbiome Drugs Market Size by Type
    9.4 Southeast Asia Microbiome Drugs Market Size by Application

10 India
    10.1 India Microbiome Drugs Market Size (2013-2018)
    10.2 Microbiome Drugs Key Players in India
    10.3 India Microbiome Drugs Market Size by Type
    10.4 India Microbiome Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Microbiome Drugs Market Size (2013-2018)
    11.2 Microbiome Drugs Key Players in Central & South America
    11.3 Central & South America Microbiome Drugs Market Size by Type
    11.4 Central & South America Microbiome Drugs Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Microbiome Drugs Introduction
        12.1.4 Pfizer Revenue in Microbiome Drugs Business (2013-2018)
        12.1.5 Pfizer Recent Development
    12.2 Second Genome
        12.2.1 Second Genome Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Microbiome Drugs Introduction
        12.2.4 Second Genome Revenue in Microbiome Drugs Business (2013-2018)
        12.2.5 Second Genome Recent Development
    12.3 Seres Therapeutics
        12.3.1 Seres Therapeutics Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Microbiome Drugs Introduction
        12.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
        12.3.5 Seres Therapeutics Recent Development
    12.4 MaaT Pharma
        12.4.1 MaaT Pharma Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Microbiome Drugs Introduction
        12.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)
        12.4.5 MaaT Pharma Recent Development
    12.5 Enterome Bioscience
        12.5.1 Enterome Bioscience Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Microbiome Drugs Introduction
        12.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)
        12.5.5 Enterome Bioscience Recent Development
    12.6 MicroBiome Therapeutics
        12.6.1 MicroBiome Therapeutics Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Microbiome Drugs Introduction
        12.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
        12.6.5 MicroBiome Therapeutics Recent Development
    12.7 Ritter Pharmaceuticals
        12.7.1 Ritter Pharmaceuticals Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Microbiome Drugs Introduction
        12.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)
        12.7.5 Ritter Pharmaceuticals Recent Development
    12.8 Rebiotix
        12.8.1 Rebiotix Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Microbiome Drugs Introduction
        12.8.4 Rebiotix Revenue in Microbiome Drugs Business (2013-2018)
        12.8.5 Rebiotix Recent Development
    12.9 OpenBiome
        12.9.1 OpenBiome Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Microbiome Drugs Introduction
        12.9.4 OpenBiome Revenue in Microbiome Drugs Business (2013-2018)
        12.9.5 OpenBiome Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Microbiome Drugs Key Market Segments
    Table Key Players Microbiome Drugs Covered
    Table Global Microbiome Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Microbiome Drugs Market Size Market Share by Type 2013-2025
    Figure Probiotics Figures
    Table Key Players of Probiotics
    Figure Prebiotics Figures
    Table Key Players of Prebiotics
    Figure Small Molecules Figures
    Table Key Players of Small Molecules
    Figure Biological Drugs Figures
    Table Key Players of Biological Drugs
    Figure Other Figures
    Table Key Players of Other
    Table Global Microbiome Drugs Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospital Pharmacies Case Studies
    Figure Retail Pharmacies Case Studies
    Figure Online Pharmacies Case Studies
    Figure Other Case Studies
    Figure Microbiome Drugs Report Years Considered
    Table Global Microbiome Drugs Market Size 2013-2025 (Million US$)
    Figure Global Microbiome Drugs Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Microbiome Drugs Market Size by Regions 2013-2025 (Million US$)
    Table Global Microbiome Drugs Market Size by Regions 2013-2018 (Million US$)
    Table Global Microbiome Drugs Market Share by Regions 2013-2018
    Figure Global Microbiome Drugs Market Share by Regions 2013-2018
    Figure Global Microbiome Drugs Market Share by Regions 2018
    Table Market Top Trends
    Table Global Microbiome Drugs Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Microbiome Drugs Market Share by Manufacturers (2013-2018)
    Figure Global Microbiome Drugs Market Share by Manufacturers in 2018
    Table Global Microbiome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Microbiome Drugs Product/Solution/Service
    Table Date of Enter into Microbiome Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table Global Microbiome Drugs Market Size Share by Type (2013-2018)
    Figure Global Microbiome Drugs Market Size Market Share by Type (2013-2018)
    Table Global Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table Global Microbiome Drugs Market Size Share by Application (2013-2018)
    Figure Global Microbiome Drugs Market Size Market Share by Application (2013-2018)
    Figure Global Microbiome Drugs Revenue Market Share by Application in 2017
    Figure United States Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table United States Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table United States Key Players Microbiome Drugs Market Share (2017-2018)
    Table United States Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table United States Microbiome Drugs Market Share by Type (2013-2018)
    Table United States Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table United States Microbiome Drugs Market Share by Application (2013-2018)
    Figure Europe Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table Europe Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table Europe Key Players Microbiome Drugs Market Share (2017-2018)
    Table Europe Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table Europe Microbiome Drugs Market Share by Type (2013-2018)
    Table Europe Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table Europe Microbiome Drugs Market Share by Application (2013-2018)
    Figure China Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table China Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table China Key Players Microbiome Drugs Market Share (2017-2018)
    Table China Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table China Microbiome Drugs Market Share by Type (2013-2018)
    Table China Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table China Microbiome Drugs Market Share by Application (2013-2018)
    Figure Japan Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table Japan Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table Japan Key Players Microbiome Drugs Market Share (2017-2018)
    Table Japan Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table Japan Microbiome Drugs Market Share by Type (2013-2018)
    Table Japan Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table Japan Microbiome Drugs Market Share by Application (2013-2018)
    Figure Southeast Asia Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Microbiome Drugs Market Share (2017-2018)
    Table Southeast Asia Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Microbiome Drugs Market Share by Type (2013-2018)
    Table Southeast Asia Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Microbiome Drugs Market Share by Application (2013-2018)
    Figure India Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table India Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table India Key Players Microbiome Drugs Market Share (2017-2018)
    Table India Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table India Microbiome Drugs Market Share by Type (2013-2018)
    Table India Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table India Microbiome Drugs Market Share by Application (2013-2018)
    Figure Central & South America Microbiome Drugs Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Microbiome Drugs Market Share (2017-2018)
    Table Central & South America Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Microbiome Drugs Market Share by Type (2013-2018)
    Table Central & South America Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Microbiome Drugs Market Share by Application (2013-2018)
    Table Pfizer Company Details
    Table Pfizer Revenue in Microbiome Drugs Business (2013-2018) (Million US$)
    Figure Pfizer Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Pfizer Recent Development
    Table Second Genome Company Details
    Table Second Genome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure Second Genome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Second Genome Recent Development
    Table Seres Therapeutics Company Details
    Table Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Seres Therapeutics Recent Development
    Table MaaT Pharma Company Details
    Table MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table MaaT Pharma Recent Development
    Table Enterome Bioscience Company Details
    Table Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Enterome Bioscience Recent Development
    Table MicroBiome Therapeutics Company Details
    Table MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table MicroBiome Therapeutics Recent Development
    Table Ritter Pharmaceuticals Company Details
    Table Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Ritter Pharmaceuticals Recent Development
    Table Rebiotix Company Details
    Table Rebiotix Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table Rebiotix Recent Development
    Table OpenBiome Company Details
    Table OpenBiome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
    Figure OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
    Table OpenBiome Recent Development
    Table Global Microbiome Drugs Market Size by Regions (Million US$) 2018-2025
    Figure Global Microbiome Drugs Market Size Share by Regions (2018-2025)
    Figure Global Microbiome Drugs Market Size Share by Regions in 2025
    Figure United States Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure China Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure India Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
    Table Global Microbiome Drugs Market Size by Product (2018-2025) (Million US$)
    Figure Global Microbiome Drugs Market Size by Product (2018-2025)
    Figure Global Microbiome Drugs Market Size by Product in 2025
    Table Global Microbiome Drugs Market Size by Application (2018-2025) (Million US$)
    Figure Global Microbiome Drugs Market Size by Application (2018-2025)
    Figure Global Microbiome Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...